Effective Date: February 28, 2025
Discover how the inclusion of Benlysta SC in the Ontario Drug Benefit Program marks a significant advancement for lupus nephritis patients, ensuring broader access to essential treatment options.
The reimbursement criteria for Benlysta SC will be listed in the Frequently Requested Drugs section on the Ministry of Health’s website:
A Summary of Listing Changes (Edition No. 43 – March 2025) has been published by the Ministry and is available for download:
The Formulary, Summaries of Changes, and Bulletins are available in a searchable electronic version (e-Formulary), which will be updated on March 31, 2025.
Lupus Canada appreciates the efforts being made to improve treatment access for lupus nephritis patients and will continue to advocate for expanded healthcare coverage.